Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
BioSpace

AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois

Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ingredients for next-generation neuroscience and obesity drugs when they ...
Business Wire

The API Innovation Center, Apertus Pharmaceuticals Bring API Production of Critical Generic Cancer Drug to U.S. Soil

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
Business Facilities

$195M AbbVie Expansion Boosts Illinois Pharma Industry

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...
NJBIZ

Cambrex to invest $120M to expand U.S. drug production

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
dbta

New API Security Testing by Cequence Enriches Testing for Pre-Production

Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...